{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0456-2212#drug","name":"Fetzima","alternateName":"LEVOMILNACIPRAN HYDROCHLORIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0456-2212"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA204168"},{"@type":"PropertyValue","propertyID":"UNII","value":"371U2ZK31U"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"f371258d-91b3-4b6a-ac99-434a1964c3af"}],"activeIngredient":"LEVOMILNACIPRAN HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"CAPSULE, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Allergan, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA204168","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0456-2212"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T20:08:50.570Z"}}